Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Clascoterone may be an effective topical treatment for hair loss.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

The SLICK1 allele in Holstein heifers affects hair and immune traits without altering prolactin signaling.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Targeting the AhR pathway may help treat alopecia areata.

FGF21 can help reduce skin inflammation caused by C. acnes.

Different genes are linked to various types of hair loss.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

17β-estradiol can reduce inflammation in the skin.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Keratinocytes contribute to hidradenitis suppurativa by causing inflammation and worsening the condition.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

IL-17-producing γδ T cells help improve bone healing.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Certain mice without specific receptors or mast cells don't lose hair from stress.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Removing anthrax toxin receptor 1 in pigs prevents Senecavirus A infection and causes a rare disease similar to GAPO syndrome.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.